Western Blot: A. aeolicus BPL/BioID2 Antibody (SS QD1) [NBP2-59940] - Analysis in total cell lysate of parental HeLa cell line (lane 1) or HeLa polyclonal cell line expressing BioID2 tagged to TorsinA delta E302/3 (6) ...read more
Immunocytochemistry/ Immunofluorescence: A. aeolicus BPL/BioID2 Antibody (SS QD1) [NBP2-59940] - Staining of HeLa cell line expressing doxycycline (dox) - inducible BioID2 tagged to TorsinA delta E302/3 with SS QD1 ...read more
Simple Western: A. aeolicus BPL/BioID2 Antibody (SS QD1) [NBP2-59940] - Lane 1: lysate from untransfected HEK293 cells. Lane 2: lysate from HEK293 cells transfected with BioID2-PTEN. A specific signal for BioID2-PTEN is ...read more
This antibody is reactive with A. aeolicus and has not been tested on other species. Simple Western was validated through a customer review.
27 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Read 1 Review rated 4 using NBP2-59940 in the following applications:
Lysates were diluted to 0.3125mg/mL before combining with 5x Fluorescent Master Mix and subjecting samples to Simple Western using default assay parameters (Protein Simple). Primary antibody to BioID2 (NBP2-59940) that was used in assay was diluted to 5ug/mL (1:200) in Antibody Diluent 2 (Protein Simple).
Product review code: SW-1WB
Product General Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.